A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Relapsing Multiple Sclerosis
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
- Status
- RECRUITING
- Phase
- PHASE2
A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Status
- RECRUITING
- Phase
- PHASE3
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
- Status
- RECRUITING
- Phase
- PHASE4
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
- Status
- RECRUITING
- Phase
- N/A
A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
- Status
- RECRUITING
- Phase
- PHASE3
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
- Status
- RECRUITING
- Phase
- N/A